Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness

MY Quan, Q Guo, J Liu, R Yang, J Bai… - Frontiers in Cell and …, 2020 - frontiersin.org
1 School of Pharmaceutical Sciences and International Collaborative Center on Growth
Factor Research, Wenzhou Medical University, Wenzhou, China, 2 Institute of Life Sciences …
被引用次数：1 相关文章

Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness (Front. Cell Dev. Biol,(2020), 8,(287), 10.3389/fcell. 2020.00287)

MY Quan, Q Guo, J Liu, R Yang… - Frontiers in Cell …, 2020 - mayoclinic.elsevierpure.com
In the original article, there was a mistake in Figures 2C, 6B, and S3C as published. The
control tubulin immunoblot shown in Figure S3C and microscopy of sphere-formation assay …

Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness

MY Quan, Q Guo, J Liu, R Yang, J Bai… - Frontiers in Cell and …, 2020 - ncbi.nlm.nih.gov
1 School of Pharmaceutical Sciences and International Collaborative Center on Growth
Factor Research, Wenzhou Medical University, Wenzhou, China, 2 Institute of Life Sciences …

Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness

MY Quan, Q Guo, J Liu, R Yang… - Frontiers in cell …, 2020 - pubmed.ncbi.nlm.nih.gov
Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness Front …

Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.

MY Quan, Q Guo, J Liu, R Yang, J Bai… - Frontiers in Cell and …, 2020 - europepmc.org
1 School of Pharmaceutical Sciences and International Collaborative Center on Growth
Factor Research, Wenzhou Medical University, Wenzhou, China, 2 Institute of Life Sciences …